The shift in immune status between microenvironment of cancer and microenvironment of matched normal tissue, including e.g. the shift in NKp30 splice variants that we observed, could serve as a biomarker for the cancer-associated virulence mediated by the cancer immunome. The gene discussed is NCR3; the disease is cancer.